Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Amifostine for Injection

Approval Number

国药准字H20227121

Company开封明仁药业有限公司

Registration Date

September 21, 2022

Previous Approval Numbers

国药准字H20113488

Drug Information

Generic Name

注射用氨磷汀

Dosage Form

注射剂

Strength

0.5g（按C₅H₁₅N₂O₃PS计）

Drug Type

化学药品

Registration Date

September 21, 2022

Company Information

Applicant Company

Company Name开封明仁药业有限公司

Company Address

开封经济开发区黄龙园区园区路8号

Manufacturing Company

Company Name开封明仁药业有限公司

Company Address

开封经济开发区黄龙园区园区路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy